TMS for PTSD in Youth
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-20
SponsorThe University of Texas Health Science Center at San Antonio
About this trial
The purpose of this study is to test whether transcranial magnetic stimulation, or TMS, is an acceptable and helpful treatment for ongoing symptoms of posttraumatic stress syndrome disorder (PTSD) in 12-20 year olds. Ongoing PTSD refers to symptoms that continue after completing trauma-focused psychotherapy. About 1 in 4 patients need additional help to overcome PTSD after completing psychotherapy. Currently, scientists do not know the best way to help adolescents with persistent PTSD, and this study will test TMS as a possible treatment, and hopefully lead to future studies including more people.
Eligibility criteria
Qualifiers
Males and females; Age 12-20
Have previously completed at least 9 sessions of trauma-focused therapy in our clinical trial or in the community
Have current self-reported symptom score of 20 or greater on the UCLA PTSD Reaction index
Willing to attend 10 TMS treatment sessions within a 30-day period
Disqualifiers
History of seizures
History of head injury with loss of consciousness and concussive sequelae
Brain abnormality such as tumor or other observable abnormality
Currently receiving psychotherapy or TMS treatment
Trial design
Treatments tested in this trial
- MagPro R30 with robotic arm
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
The University of Texas Health Science Center at San Antonio
Lead sponsor
Texas Child Mental Health Care Consortium: TCMHCC
Collaborator
Source ClinicalTrials.gov